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Blood pressure variabilityAbstract Background: Blood pressure (BP) has been shown to exhibit important variations not
only in the short term but also over more prolonged periods of time.
Aim: To evaluate the impact of different ambulatory BP variability indices on left ventricular
hypertrophy (LVH) in controlled hypertensive patients (Pts).
Patients and methods: Ninety controlled hypertensive Pts (ofﬁce and ambulatory BP control
criteria) with mean age 55.9 ± 8.5 years were enrolled. Pts were classiﬁed into two groups:
Non-LVH group including 75 Pts with normal LV mass index and LVH group including 15 patients
with LV mass index >134 g/m2 in men and >110 g/m2 in women. Mean BP and BP load values
were obtained for the full 24 h and day-time and night-time periods. Similarly Standard
Deviation (SD) and Average Reading Variability (ARV) were calculated in all pts.
Results: Regarding ofﬁce BP, Dipping status and average ambulatory BP, there was no statistically
signiﬁcant difference between both groups. Meanwhile, SD of BP readings and ARV showed a
signiﬁcant difference. After step-wise regression, ARV of systolic BP 24 h was the most powerful
variability index that was associated with LVH (R2 = 0.944). The ROC curve analysis showed that
the discriminative power was best at more than 14.23 mmHg with sensitivity and speciﬁcity 100%
and 96% respectively for prediction of LVH.
Conclusion: The adverse cardiovascular consequences of hypertension not only depend on mean
BP values but may also depend on BPV, which independently adds to CV risk over elevated mean
BP levels.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hypertension has a serious harmful effect on the physiological
and biochemical functions of heart that end with the appear-
ance of cardio-vascular diseases.1 Blood pressure is character-
ized by large spontaneous variations from time to time in ahypertensive patient during the day and between days, months
and seasons so called blood pressure variability (BPV).2 It is an
independent predictor of progression of subclinical organ
damage (i.e., increased left ventricular mass index or carotid
intima-media thickness)3 and cardiovascular (CV) mortality.4
Accordingly, the purpose of the present work was to evalu-
ate the impact of different ambulatory BP variability indices
on left ventricular hypertrophy (LVH) in controlled hyper-
tensive patients (Pts).
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This prospective study included 90 hypertensive pts who pre-
sented to Minia University hospital outpatient cardiology
clinic, during the period from May 2013 to May 2014 for
regular follow up of blood pressure.
All included pts had a history of hypertension for at least
3 years, and were compliant on antihypertensive treatment
for at least the last year and their ofﬁce blood pressure (BP)
and ambulatory blood pressure monitoring (ABPM)
represented controlled hypertension (i.e. <140/90 mmHg
ofﬁce BP readings and <135/85 mmHg average 24 h ABPM
readings respectively). Smoking, Diabetes Mellitus, renal
impairment, Impaired LV systolic function (LVEF 45%),
valvular heart disease, coronary artery disease, atrial ﬁb-
rillation and obesity were the exclusion criteria.
The studied pts were subjected to the following:
1. Full detailed clinical evaluation including blood pressure
measurements at morning hours in sitting position after
at least 5 min of rest. An average value of 3 measurements
was obtained. BMI (kg/m2) and BSA (m2) were calculated
and Local cardiac examination was performed.
2. Laboratory investigations: including fasting blood sugar
and Serum creatinine.
3. 24-h ambulatory BP monitoring: Pts were ﬁtted with an
ABPM device (Contec model ABPM 50, China).
The device was programmed to obtain BP readings at 15-
min interval during the day (07:00–23:00 h) and at 30-min
intervals during the night (23:00–07:00 h). Mean systolic BP
(SBP), Diastolic BP (DBP), Mean arterial pressure (MAP)
and BP load values were obtained for the full 24 h, day-time
and night-time periods.
I Calculation of blood pressure variability indices:
 Dipping status: Normal dippers are deﬁned as those with
average night BP decreasing 10–20% of the average
daytime BP. Non-dippers are those with average night BP
decreasing 0–10% of the average daytime BP. Extreme-dip-
pers are those with average night BP decreasing >20% of
the average daytime BP. Meanwhile, reversed dippers are
those with average night BP higher than the average
daytime BP.
 Standard Deviation (SD) and Average Reading Variability
(ARV) of 24 h BP, daytime BP and nighttime BP (systolic &
diastolic) were calculated
i. Standard Deviation (SD)3:
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(N) Number of valid blood pressure (BP) measurements –
(K) ranges from 1 to N  1 – (P) denotes that we sum
across the values.
I Trans-thoracic echocardiography.
 Echocardiography examination was performed by using
General Electric Vivid 3 ultrasound with simultaneous
ECG tracing. The measurements represent a mean of 3 con-
secutive cardiac cycles.
 Left ventricular mass (LV Mass) was calculated by
Devereux’s formula.5 as follows:
 LV mass = 0.8 [1.04{(IVSd + LVEDd + PWTd)3 
LVEDd3}] + 0.6 g.
 BSA is calculated by Mosteller square root method6
 BSA=Height (m) ·Weight (kg)/36 (m2).
 LV mass Index (LVMI) = LVmass
BSA
(g/m2).
According to this formula, LVMI is increased if >134 g/m2
in men and >110 g/m2 in women.5
3. Statistical methodology
The Statistical Package of SPSS version 16 for windows was
used for data entry and analysis. Standard descriptive statistics
were done and all values were given as mean ± SD.
Correlations were done by Pearson correlation coefﬁcient
test. Correlation was considered signiﬁcant if its P value
was <0.05.
Multivariate stepwise regression analyses were done for all
ABPM indices that showed signiﬁcant correlation with
LVMI. Roc curve analysis was done for the most powerful
ABPM index detected by multivariate stepwise regression
analysis.
4. Results
Based on echocardiographic measurement of LV mass index
(g/m2), patients were classiﬁed into two groups:
A – Non-LVH group. This group included 75 patients.
B – LVH group (where LV mass index is >134 g/m2 in men
and >110 g/m2 in women). This group included 15 patients.
There was no statistically signiﬁcant difference between
Non-LVH group and LVH group as regard age, sex and
duration of hypertension. (Table 1).ge, sex and hypertension duration.
LVH (n= 75) LVH (n= 15) P value
± 8.76 57.07 ± 7.02 0.585
3/12 0.100
2.99 5. 24 ± 3.61 <0.07
Table 2 Comparison between Non-LVH group and LVH group regarding ofﬁce BP, Dipping status, (24 h, daytime and nighttime)
average BP and blood pressure load.
Non-LVH (n= 75) Mean ± SD LVH (n= 15) Mean ± SD P value
Oﬃce systolic BP (mmHg) 134.33 ± 8.75 132.67 ± 8.61 0.511
Oﬃce diastolic BP (mmHg) 77.07 ± 8.1 80.67 ± 7.99 0.119
Dipping status: n (%)
Dipper 17 (22.7%) 3 (20%) 0.898
Non dipper 42 (56%) 8 (53.3%)
Reversed dipper 16 (21.3%) 4 (26.7%)
Average systolic BP 24 h (mmHg) 122.27 ± 9.06 124.73 ± 9.22 0.346
Average diastolic BP 24 h (mmHg) 67.51 ± 9.35 71.53 ± 8.43 0.126
Average systolic BP daytime (mmHg) 121.01 ± 9.62 126.47 ± 10.47 0.051
Average diastolic BP daytime (mmHg) 69.27 ± 9.65 72.87 ± 9.09 0.186
Average systolic BP nighttime (mmHg) 114.97 ± 10.34 119.67 ± 11.47 0.119
Average diastolic BP nighttime (mmHg) 63.93 ± 8.98 67 ± 8.75 0.229
Systolic BP load 24 h (%) 19.53 ± 16.47 30.63 ± 17.73 0.023
Diastolic BP load 24 h (%) 8.73 ± 10.23 17.91 ± 12.65 0.004
Systolic BP load daytime (%) 12.18 ± 14.1 26.23 ± 17.52 0.003
Diastolic BP load daytime (%) 7.09 ± 10.28 17.03 ± 14.12 0.001
Systolic BP load nighttime (%) 34.95 ± 28.27 44.07 ± 26.72 0.179
Diastolic BP load nighttime (%) 11.74 ± 14.71 25.29 ± 21.97 0.013
LVH= left ventricular hypertrophy and BP = blood pressure.
Table 3 Comparison between Non-LVH group and LVH group regarding standard deviation of BP readings and Average Reading
Variability in 24 h, daytime and nighttime recordings.
Non-LVH (n= 75) Mean ± SD LVH (n= 15) Mean ± SD P value
SD of systolic BP 24 h (mmHg) 13.79 ± 2.53 19.05 ± 3.2 <0.001
SD of diastolic BP 24 h (mmHg) 11.54 ± 2.81 16.57 ± 4.25 <0.001
SD of systolic BP daytime (mmHg) 13.37 ± 2.91 18.83 ± 3.49 <0.001
SD of diastolic BP daytime (mmHg) 11.31 ± 3.1 16.76 ± 4.68 <0.001
SD of systolic BP nighttime (mmHg) 11.41 ± 3.07 15.29 ± 2.77 <0.001
SD of diastolic BP nighttime (mmHg) 9.12 ± 2.36 12.11 ± 3 <0.001
ARV of systolic BP 24 h (mmHg) 10.88 ± 2.17 16.76 ± 2.17 <0.001
ARV of diastolic BP 24 h (mmHg) 9.03 ± 2.07 14.6 ± 3.89 <0.001
ARV of systolic BP daytime (mmHg) 11.04 ± 2.45 17.38 ± 2.77 <0.001
ARV of diastolic BP daytime (mmHg) 9.29 ± 2.39 15.35 ± 4.56 <0.001
ARV of systolic BP nighttime (mmHg) 10.29 ± 3.19 14.53 ± 2.45 <0.001
ARV of diastolic BP nighttime (mmHg) 8.08 ± 2.53 11.9 ± 3.22 <0.001
LVH= left ventricular hypertrophy, BP = blood pressure, AVR= Average Reading Variability and SD= Standard deviation.
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both groups as regard ofﬁce BP, Dipping status and (24 h,
daytime and nighttime) average ambulatory BP readings.
Meanwhile, standard deviation and Average Reading
Variability of (24 h, daytime and nighttime) BP showed
statistically signiﬁcant difference between both groups. Also
24 h, daytime, diastolic nighttime BP load showed the same
behavior (Tables 2 and 3).
There was a weak correlation between LVMI and Blood
Pressure Load, fair to moderate correlation between LVMI
and SD of BP readings and moderate to strong correlation
between LVMI and ARV (Table 4). After step-wise regression,
ARV of systolic BP 24 h was the most powerful ABPM
parameter that could predict LVH (R2 = 0.944). The dis-
criminative power of ARV of systolic BP 24 h was best at
more than 14.23 mmHg with sensitivity and speciﬁcity 100%
and 96% respectively (Fig. 1).5. Discussion
BP variations in the very short term (i.e., beat to beat) and in
the short term (i.e., within 24 h) mainly reﬂect the inﬂuences of
central neural factors either in response to behavioral
challenges or as a result of rhythmic inﬂuences originating in
the central nervous system or the inﬂuences of reﬂex auto-
nomic modulation.7–10 An increased central sympathetic drive
and reduced sensitivity of arterial and cardiopulmonary
reﬂexes may both lead to an increased BPV.7–10 In this context,
changes in elastic properties of large arteries (i.e., an increased
arterial stiffness)11 and the effects of humoral (insulin,
angiotensin II, bradykinin, endothelin-1, and nitric oxide)
and rheological (i.e., blood viscosity) factors12 may play a role.
In addition, BP ﬂuctuations also occur in response to the
mechanical forces generated by ventilation.
Table 4 Correlations between ABPM parameters (With
signiﬁcant statistical difference) and LV mass index.
LV Mass index with R P
Systolic BP load 24 h 0.136 0.023
Diastolic BP load 24 h 0.126 0.004
Systolic BP load daytime 0.306 0.003
Diastolic BP load daytime 0.190 0.001
Diastolic BP load nighttime 0.114 0.013
SD of systolic BP 24 h 0.795 <0.001
SD of diastolic BP 24 h 0.635 <0.001
SD of systolic BP daytime 0.782 <0.001
SD of diastolic BP daytime 0.631 <0.001
SD of systolic BP nighttime 0.498 <0.001
SD of diastolic BP nighttime 0.372 <0.001
ARV of systolic BP 24 h 0.972 <0.001
ARV of diastolic BP 24 h 0.729 <0.001
ARV of systolic BP daytime 0.936 <0.001
ARV of diastolic BP daytime 0.705 <0.001
ARV of systolic BP nighttime 0.636 <0.001
ARV of diastolic BP nighttime 0.514 <0.001
SD= Standard deviation, BP = blood pressure and AVR=Aver-
age Reading Variability.
Figure 1 Roc curve analysis of ARV of systolic BP 24 h versus
LVH.
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between ABPM variability indices [Standard Deviation (SD)
and Average Reading Variability (ARV)] and LVMI.
Average Reading Variability (ARV) of systolic blood pressure
24 h was the most powerful ABPM variability index in
prediction of abnormally increased LVMI.
The evidence that ABPM gives information over and above
conventional BP measurement has been growing steadily over
the past 25 years, and the rationale for its use in clinical prac-
tice is soundly based. The principal advantages of ABPM are
the number of readings obtained in the outpatient setting.
Frequent readings lead a closer estimate of ‘true BP’ and allow
for the analysis of BP variability and circadian rhythm of BP.13
Recently, Angeli et al. concluded that end organ damageassociated with hypertension is more closely related to ambula-
tory BP than clinic or casual BP measurements, and it is now
well established that ambulatory BP measurements give better
prediction of clinical outcomes compared with conventional
ofﬁce BP measurements.13
Our study actually conﬁrms Frattola et al., observation that
hypertensive patients with the same 24-h BP mean values and
greater BP variability have shown overall target organ damage
and left ventricular mass index more than patients with a lesser
BP variability.14 However, their patients were hypertensive
with different levels of control (four groups according to
whether their 24 h average mean arterial pressure was less than
95 mmHg, 95–108 mmHg, 109–120 mmHg or more than
120 mmHg). Twenty-four hour blood pressure was measured
intra-arterially by the oxford method15 and the two indices
for blood pressure variability evaluation were the average of
the standard deviations obtained for each half hour (within
half hour standard deviation) and the standard deviation of
the average of the half hour mean values (among half hour
standard deviation).
Sasaki et al., showed that inducing increase in blood
pressure variability without blood pressure elevation by
sinoaortic denervation (SAD) in rats, would be followed by
cardiovascular damage. They hypothesized that the organ
damage accompanying hypertension was in part due to the
extent of the BP variability and thus not only average BP
values but also upward and downward BP excursions around
them should be reduced by the treatment.16
The PAMELA study (Pressioni Arteriose Monitorate E
Loro Associazioni) investigated the relationship between BP
variability and target organ damage in general population
(not only hypertensive patients). This study actually provided
the ﬁrst demonstration in the general population that there is
also a positive independent association between LVMI and
BPV.17
In their study, Hansen et al. used the International
Database on Ambulatory Blood Pressure in Relation to
Cardiovascular Outcome that included prospective studies
from 11 centers (8938 Subjects). These data were used to assess
short-term reading-to-reading blood pressure variability by
two different parameters, the ﬁrst one is the usual Standard
Deviation (SD) and the second one is the Average Reading
Variability (ARV). This group of population underwent a fol-
low-up of 11.3 years in average for mortality (Cardiovascular
and Non-cardiovascular), cardiovascular complications
(Fatal and Non-fatal). Finally this study concluded that1:
Blood pressure variability was a signiﬁcant and independent
predictor of mortality and of cardiovascular and stroke
events.2 ARV was a better predictor than SD24, probably
because subjects with different blood pressure proﬁles might
have similar SD but different ARV. Thus, ARV might be a
more speciﬁc measure of blood pressure variability than SD.3
Short-term BPV has been associated with left ventricular
hypertrophy in normotensive Africans in the SABPA
Study.18 The study included 409 african and caucasian teachers
aged 25–60 years showing a positive correlation between 24 h
systolic BPV and markers of left ventricular hypertrophy in
African but not Caucasian normotensive subjects.
Considering this association, the authors stress out that the
assessment of short-term BPV could potentially add to the
early detection of normotensive Africans at increased risk for
the development of cardiovascular complications.18
Left ventricular hypertrophy in controlled hypertension 63Wei et al., 2014 and Ryu et al., 2014 showed that although
included patients had a similar 24-h mean BP values, patients
with higher BP variability had a greater comprehensive score
for organ damage.19,20
Although, both Mancia et al., 2002 and Sega et al., 2005
showed no signiﬁcant correlation between LVMI and BP vari-
ability assessed by 24-h SD, and demonstrated a signiﬁcant
correlation between LVMI and mean BP values,17,21 yet this
has been challenged by many studies specially those that test
the newer variability parameter ARV.
The demonstration that the patients with LVH are still
showing increased blood pressure variability despite the per-
fectly controlled BP, sheds a strong light on the role of BPV
on the pathogenesis of target organ damage in arterial
hypertension.6. Conclusion
Based on the results of this study, we can conclude that blood
pressure variability is an important issue to be studied in
hypertensive patients that might contribute to the pathogenesis
of target organ damage even after control of BP. The ARV as
an index of BP variability is superior to the traditional index
(SD) in prediction of increased LV mass. At a cutoff value
of 14.23 mmHg, the ARV of 24 h systolic BP could predict
the presence of increased LVMI above normal values with a
sensitivity of 100% and speciﬁcity of 96%.Conﬂict of Interest
We have no conﬂict of interest.
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